Can wearable devices provide the right insights and clinical-quality data to monitor and research the progression or regression of rare diseases thus accelerating medical advancements? Watch a recording of our webinar where Empatica and Takeda engage in a discussion about wearables in research, their evolution and applications in various clinical fields, and early insights from a groundbreaking study leveraging a unique set of measures collected by Empatica’s EmbracePlus.
Our Speakers:
- Rosalind Picard, SdC - Director and Founder of the Affective Computing Group at the MIT Media Lab and Faculty Chair, MIT Mind+Hand+Heart Wellbeing Initiative. Picard is an active inventor with multiple patents, including wearable and non-contact sensors, algorithms, and systems for sensing, recognizing, and responding respectfully to human affective information.
- Marisa Cruz, MD - Chief Medical Officer of Empatica. She blends a passion for patient care with deep experience in digital health and regulatory policy, leveraging previous roles as the Chief Medical Officer of Limbix Health, the EVP of Regulatory and Clinical Affairs at Everly Health, and the Senior Medical Advisor for the Digital Health Unit at the US Food and Drug Administration.
- Ariel Dowling, PhD - Head of Sensing and Measurement, Data Sciences Institute at Takeda Pharmaceuticals. Ariel holds an MS and PhD in Mechanical Engineering from Stanford University and an AB and BE in Mechanical Engineering from Dartmouth College. She currently serves on the Strategic Advisory Board of the Digital Medicine (DiMe) Society.
Register today and gain immediate access to our on-demand webinar: Using Wearables for Rare Disease Monitoring and Research.
